MRNA - Marina Biotech, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue--500
Cost of Revenue---
Gross Profit--500
Operating Expenses
Research Development108.858322.317686
Selling General and Administrative599.683785.2613,334
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-757.73-1,107.578-3,520
Income from Continuing Operations
Total Other Income/Expenses Net-75.1-75.1-1,951
Earnings Before Interest and Taxes-836.343-1,106.964-5,476
Interest Expense--1,006
Income Before Tax-836.343-1,106.964-6,482
Income Tax Expense0.81.6-
Minority Interest---
Net Income From Continuing Ops-837.143-1,108.564-6,477
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-837.143-1,108.564-6,477
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-837.143-1,108.564-12,477